Lexicon Pharmaceuticals
LXRX
#7133
Rank
A$0.89 B
Marketcap
A$2.02
Share price
-4.05%
Change (1 day)
-1.20%
Change (1 year)

EPS for Lexicon Pharmaceuticals (LXRX)

EPS in 2026 (TTM): A-$0.22

According to Lexicon Pharmaceuticals 's latest financial reports the company's current EPS (TTM) is A-$0.21. In 2025 the company made an earnings per share (EPS) of A-$0.20 an increase over its 2024 EPS that were of A-$0.91.

EPS history for Lexicon Pharmaceuticals from 2012 to 2026

Annual EPS

Year EPS Change
2026 (TTM)A-$0.2211.3%
2025A-$0.20-78.13%
2024A-$0.91-20%
2023A-$1.1431.15%
2022A-$0.87-0%
2021A-$0.8710.91%
2020A-$0.78-145.08%
2019A$1.73-206.09%
2018A-$1.63-5.74%
2017A-$1.73-10.95%
2016A-$1.952640%
2015A-$0.07107-96.34%
2014A-$1.94-2.53%
2013A-$1.99-9.09%
2012A-$2.19

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Thermo Fisher Scientific
TMO
A$26.47-12,513.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Illumina
ILMN
A$7.69-3,706.67%๐Ÿ‡บ๐Ÿ‡ธ USA
Regeneron Pharmaceuticals
REGN
A$59.57-28,040.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Ultragenyx Pharmaceutical
RARE
A-$8.30 3,793.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
A$14.23-6,773.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
A-$0.02843-86.67%๐Ÿ‡บ๐Ÿ‡ธ USA
Aerie Pharmaceuticals
AERI
A-$1.07 400.00%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
A$0.54-353.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Eterna Therapeutics
ERNA
A-$41.63 19,426.67%๐Ÿ‡บ๐Ÿ‡ธ USA